Advanced ADME/PK/PD Modeling and Simulation Training Course

Course Title: Advanced ADME/PK/PD Modeling and Simulation Training Course

Executive Summary

This intensive two-week course provides a deep dive into advanced ADME/PK/PD modeling and simulation techniques essential for modern drug development. Participants will gain hands-on experience with state-of-the-art software and methodologies to predict drug absorption, distribution, metabolism, excretion, and pharmacodynamics. Emphasis is placed on quantitative systems pharmacology (QSP), physiologically-based pharmacokinetic (PBPK) modeling, and non-compartmental analysis. Real-world case studies and practical exercises enable participants to apply these techniques to optimize drug design, predict clinical outcomes, and support regulatory submissions. The course equips participants with the skills to enhance drug development efficiency, reduce costs, and improve patient outcomes through model-informed drug development (MIDD).

Introduction

The landscape of drug development is rapidly evolving, driven by the need for faster, more efficient, and cost-effective processes. Advanced ADME/PK/PD modeling and simulation are integral to achieving these goals. This course provides a comprehensive training program focused on the theoretical underpinnings and practical applications of these techniques. Participants will learn how to use modeling and simulation to optimize drug candidates, predict clinical outcomes, and inform regulatory decisions. The curriculum covers a range of modeling approaches, from classical compartmental PK/PD models to more complex PBPK and QSP models. Through a combination of lectures, hands-on workshops, and case studies, participants will develop the skills needed to leverage these powerful tools to accelerate drug development and improve patient care. This course is designed for professionals seeking to enhance their expertise in model-informed drug development and contribute to the advancement of pharmaceutical research.

Course Outcomes

• Apply advanced ADME/PK/PD modeling and simulation techniques.
• Develop and validate PBPK models to predict drug disposition.
• Utilize QSP models to understand drug-target interactions.
• Perform non-compartmental analysis and interpret results.
• Optimize drug dosing regimens using PK/PD modeling.
• Apply modeling and simulation to support regulatory submissions.
• Integrate model-informed drug development (MIDD) into drug development workflows.

Training Methodologies

• Interactive lectures and discussions
• Hands-on software workshops using industry-standard tools
• Case study analysis of real-world drug development scenarios
• Group projects to develop and apply ADME/PK/PD models
• Expert guest lectures from industry and academia
• Individual coaching and feedback sessions
• Practical exercises and simulations to reinforce learning

Benefits to Participants

• Enhanced understanding of ADME/PK/PD principles
• Proficiency in using industry-standard modeling software
• Improved ability to predict drug behavior in vivo
• Skills to optimize drug dosing and minimize toxicity
• Increased confidence in model-informed decision making
• Expanded professional network within the pharmaceutical industry
• Certification recognizing advanced ADME/PK/PD modeling expertise

Benefits to Sending Organization

• Accelerated drug development timelines
• Reduced development costs through virtual experiments
• Improved success rates in clinical trials
• Enhanced ability to predict drug-drug interactions
• Optimized drug dosing regimens for improved patient outcomes
• Stronger regulatory submissions based on robust modeling data
• Increased competitiveness in the pharmaceutical market

Target Participants

• Pharmacokineticists and pharmacodynamicists
• Drug metabolism and toxicology scientists
• Formulation scientists
• Clinical pharmacologists
• Regulatory affairs professionals
• Pharmaceutical scientists
• Researchers involved in drug discovery and development

WEEK 1: Foundations and Compartmental Modeling

Module 1: Introduction to ADME/PK/PD

1. Overview of ADME processes and their importance
2. Fundamentals of pharmacokinetics and pharmacodynamics
3. Introduction to modeling and simulation concepts
4. Compartmental vs. non-compartmental analysis
5. Introduction to relevant software tools
6. Overview of Model-Informed Drug Development (MIDD)
7. Ethical considerations in modeling

Module 2: Non-Compartmental Analysis (NCA)

1. Principles of NCA
2. Calculation of PK parameters (AUC, Cmax, Tmax, etc.)
3. Statistical considerations in NCA
4. Application of NCA to drug development
5. Hands-on NCA using software
6. Interpretation of NCA results
7. Limitations of NCA

Module 3: One-Compartment Modeling

1. Development of one-compartment models
2. IV bolus and IV infusion administration
3. First-order elimination kinetics
4. Estimation of PK parameters (kel, Vd)
5. Model fitting and validation
6. Hands-on model building and simulation
7. Clinical applications of one-compartment models

Module 4: Two-Compartment Modeling

1. Development of two-compartment models
2. Distribution phase and elimination phase
3. Estimation of PK parameters (k12, k21, kel, Vc, Vp)
4. Model fitting and validation
5. Hands-on model building and simulation
6. Clinical applications of two-compartment models

Module 5: Multi-Compartment Modeling and Model Selection

1. Advanced compartment models
2. Model selection criteria (AIC, BIC)
3. Residual analysis
4. Model diagnostics and validation
5. Goodness-of-fit assessment
6. Practical examples of model selection
7. Software tools for model assessment

WEEK 2: Advanced Modeling and Simulation

Module 6: Physiological-Based Pharmacokinetic (PBPK) Modeling

1. Principles of PBPK modeling
2. Anatomical and physiological considerations
3. Drug-specific properties (MW, LogP, pKa)
4. Building and validating PBPK models
5. Hands-on PBPK modeling
6. Applications in drug development and regulatory submissions
7. Limitations of PBPK models

Module 7: Quantitative Systems Pharmacology (QSP) Modeling

1. Introduction to QSP modeling
2. Systems biology and drug action
3. Building QSP models for drug-target interactions
4. Model calibration and validation
5. Hands-on QSP modeling
6. Applications in drug discovery and development
7. Future trends in QSP modeling

Module 8: Population PK/PD Modeling

1. Principles of population PK/PD modeling
2. Inter-individual variability and covariate analysis
3. Nonlinear mixed-effects modeling (NLME)
4. Model building and validation
5. Applications in clinical trial simulation
6. Hands-on population PK/PD modeling
7. Interpretation of population PK/PD results

Module 9: Simulation and Prediction

1. Monte Carlo simulation
2. Sensitivity analysis
3. Virtual bioequivalence studies
4. Dose optimization
5. Prediction of drug-drug interactions
6. Applications in clinical trial design
7. Hands-on simulation and prediction

Module 10: Regulatory Applications and Case Studies

1. Regulatory guidelines for ADME/PK/PD modeling
2. Preparation of modeling reports for regulatory submissions
3. Case studies of successful modeling applications
4. Common pitfalls and challenges
5. Future trends in regulatory science
6. Discussion of ethical considerations
7. Course summary and wrap-up

Action Plan for Implementation

1. Identify a specific project within your organization where ADME/PK/PD modeling can be applied.
2. Develop a detailed project plan with clear objectives, timelines, and resource allocation.
3. Select appropriate software tools and training resources.
4. Form a multidisciplinary team with expertise in pharmacology, toxicology, and clinical development.
5. Implement the modeling and simulation techniques learned in the course.
6. Monitor the progress of the project and adjust the plan as needed.
7. Share the results with your organization and publish the findings in peer-reviewed journals.